522 related articles for article (PubMed ID: 17911499)
1. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.
Ahimastos AA; Aggarwal A; D'Orsa KM; Formosa MF; White AJ; Savarirayan R; Dart AM; Kingwell BA
JAMA; 2007 Oct; 298(13):1539-47. PubMed ID: 17911499
[TBL] [Abstract][Full Text] [Related]
2. A role for plasma transforming growth factor-beta and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome?
Ahimastos AA; Aggarwal A; Savarirayan R; Dart AM; Kingwell BA
Atherosclerosis; 2010 Mar; 209(1):211-4. PubMed ID: 19717156
[TBL] [Abstract][Full Text] [Related]
3. Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial.
Williams A; Kenny D; Wilson D; Fagenello G; Nelson M; Dunstan F; Cockcroft J; Stuart G; Fraser AG
Eur J Clin Invest; 2012 Aug; 42(8):891-9. PubMed ID: 22471392
[TBL] [Abstract][Full Text] [Related]
4. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome.
Groenink M; de Roos A; Mulder BJ; Spaan JA; van der Wall EE
Am J Cardiol; 1998 Jul; 82(2):203-8. PubMed ID: 9678292
[TBL] [Abstract][Full Text] [Related]
5. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension.
Pannier BM; Guerin AP; Marchais SJ; London GM
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1074-7. PubMed ID: 11903319
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II blockade in Marfan's syndrome.
Ahimastos AA; Dart AM; Kingwell BA
N Engl J Med; 2008 Oct; 359(16):1732; author reply 1733-4. PubMed ID: 18923178
[No Abstract] [Full Text] [Related]
7. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers.
Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J
Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069
[TBL] [Abstract][Full Text] [Related]
8. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture.
Ahimastos AA; Natoli AK; Lawler A; Blombery PA; Kingwell BA
Hypertension; 2005 Jun; 45(6):1194-9. PubMed ID: 15897362
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome.
Bhatt AB; Buck JS; Zuflacht JP; Milian J; Kadivar S; Gauvreau K; Singh MN; Creager MA
Vasc Med; 2015 Aug; 20(4):317-25. PubMed ID: 25795452
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Effect of Aliskiren Versus Negative Controls on Aortic Stiffness in Patients With Marfan Syndrome Under Treatment With Atenolol.
Hwang JW; Kim EK; Jang SY; Chung TY; Ki CS; Sung K; Kim SM; Ahn J; Carriere K; Choe YH; Chang SA; Kim DK
Rev Esp Cardiol (Engl Ed); 2018 Sep; 71(9):743-749. PubMed ID: 29198406
[TBL] [Abstract][Full Text] [Related]
12. Impaired Central Pulsatile Hemodynamics in Children and Adolescents With Marfan Syndrome.
Grillo A; Salvi P; Marelli S; Gao L; Salvi L; Faini A; Trifirò G; Carretta R; Pini A; Parati G
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29114001
[TBL] [Abstract][Full Text] [Related]
13. Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome.
Jeremy RW; Huang H; Hwa J; McCarron H; Hughes CF; Richards JG
Am J Cardiol; 1994 Aug; 74(4):369-73. PubMed ID: 8059700
[TBL] [Abstract][Full Text] [Related]
14. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial.
Mullen M; Jin XY; Child A; Stuart AG; Dodd M; Aragon-Martin JA; Gaze D; Kiotsekoglou A; Yuan L; Hu J; Foley C; Van Dyck L; Knight R; Clayton T; Swan L; Thomson JDR; Erdem G; Crossman D; Flather M;
Lancet; 2019 Dec; 394(10216):2263-2270. PubMed ID: 31836196
[TBL] [Abstract][Full Text] [Related]
15. Perindopril: the reasonable choice in patients with coronary artery disease.
Cockcroft JR
Int J Clin Pract; 2005 May; 59(5):600-4. PubMed ID: 15857358
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term beta-blockade on aortic root compliance in patients with Marfan syndrome.
Rios AS; Silber EN; Bavishi N; Varga P; Burton BK; Clark WA; Denes P
Am Heart J; 1999 Jun; 137(6):1057-61. PubMed ID: 10347331
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
Asmar RG; Pannier BM; London GM; Safar ME
Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():79-83. PubMed ID: 1838923
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome.
Yetman AT; Bornemeier RA; McCrindle BW
Am J Cardiol; 2005 May; 95(9):1125-7. PubMed ID: 15842990
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK).
Kiru G; Bicknell C; Falaschetti E; Powell J; Poulter N
Health Technol Assess; 2016 Jul; 20(59):1-180. PubMed ID: 27488944
[TBL] [Abstract][Full Text] [Related]
20. Aortic dilatation in Marfan syndrome: role of arterial stiffness and fibrillin-1 variants.
Salvi P; Grillo A; Marelli S; Gao L; Salvi L; Viecca M; Di Blasio AM; Carretta R; Pini A; Parati G
J Hypertens; 2018 Jan; 36(1):77-84. PubMed ID: 29210860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
